STAT Plus: As CRISPR patent fight nears the endgame, where are settlement talks?

With an appeals court ruling expected soon on key U.S. CRISPR patents, experts are wondering whether the Broad Institute and the University of California will resume settlement talks.

More From BioPortfolio on "STAT Plus: As CRISPR patent fight nears the endgame, where are settlement talks?"